Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balance peritoneal dialysis solution versus conventional stay-safe solution in end-stage renal disease
ACTRN12606000044527Phase 4Recruiting
- Sponsor
- Fresenius Medical Care
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of balance in end-stage kidney disease (ESKD) (2 arms), sponsored by Fresenius Medical Care. Primary endpoint: Evolution of residual renal function. Started Aug 2004; status: recruiting.
02
Drugs
balance
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ACTRN12606000044527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000044527.